Magnetic intracellular labeling of mammalian cells by combining (FDA-approved) superparamagnetic iron oxide MR contrast agents and commonly used transfection agents.
Frank
Joseph A
JA
Experimental Neuroimaging Section, Laboratory of Diagnostic Radiology Research, National Institutes of Health, Bethesda, MD 20892-1074, USA.
Zywicke
Holly
H
Jordan
E K
EK
Mitchell
Jennifer
J
Lewis
Bobbi K
BK
Miller
Brad
B
Bryant
L Henry
LH
Bulte
Jeff W M
JW
D000818:Animals; D002411:Cation Exchange Resins / Q000494:pharmacology; D002478:Cells, Cultured / Q000378:metabolism*; D003287:Contrast Media / Q000494:pharmacology*; D003911:Dextrans; D052203:Ferrosoferric Oxide; D006801:Humans; D007202:Indicators and Reagents / Q000494:pharmacology*; D007501:Iron / Q000494:pharmacology*; D008055:Lipids / Q000494:pharmacology; D008214:Lymphocytes / Q000378:metabolism; D008279:Magnetic Resonance Imaging; D058185:Magnetite Nanoparticles; D009836:Oligodendroglia / Q000378:metabolism; D010087:Oxides / Q000494:pharmacology*; D013234:Stem Cells / Q000378:metabolism; D014162:Transfection; D014407:Tumor Cells, Cultured / Q000378:metabolism
D002411:Cation Exchange Resins; D003287:Contrast Media; D003911:Dextrans; D007202:Indicators and Reagents; D008055:Lipids; C086724:Lipofectamine; D058185:Magnetite Nanoparticles; D010087:Oxides; D007501:Iron; C065507:ferumoxides; D052203:Ferrosoferric Oxide